Literature DB >> 8985357

The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element.

C Nonkwelo1, I K Ruf, J Sample.   

Abstract

Expression of the Epstein-Barr virus (EBV) EBNA-1 protein within EBV-positive tumor cells and subpopulations of latently infected B lymphocytes in vivo is mediated by the promoter Qp. Previous studies have established that Qp is a TATA-less promoter whose activation requires only proximal regulatory elements and that it is negatively autoregulated through two EBNA-1 binding sites downstream of the transcription initiation sites. The objective of this study was to better define the properties of an essential positive regulatory element (QRE-2) adjacent to a major transcription start site of Qp and to evaluate the contributions of other potential regulatory elements proximal to the Qp start site. Using DNA affinity purification and UV cross-linking, we have identified the QRE-2-binding protein as a single polypeptide of approximately 40 kDa. The DNA-binding properties of this protein are clearly distinct from those of the TATA-binding protein, suggesting that in the absence of a TATA box, QRE-2 may function as an initiator element to direct assembly of TFIID near the transcription start site. Mutational analysis of potential regulatory elements, furthermore, indicated that the putative E2F binding sites within the EBNA-1 binding domain can exert a positive influence on Qp that is EBNA-1 independent, suggesting that these regulatory elements play an additional if not different role in Qp regulation than previously proposed. A model for the regulation of Qp consistent with the current and previous findings which provides for a simple but efficient mechanism of ensuring the EBNA-1 expression necessary to sustain long-term latency is presented.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985357      PMCID: PMC191058     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site.

Authors:  J Sample; M Hummel; D Braun; M Birkenbach; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

2.  Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.

Authors:  C L Chen; R H Sadler; D M Walling; I J Su; H C Hsieh; N Raab-Traub
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

3.  An alternative pathway for transcription initiation involving TFII-I.

Authors:  A L Roy; S Malik; M Meisterernst; R G Roeder
Journal:  Nature       Date:  1993-09-23       Impact factor: 49.962

4.  Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.

Authors:  R J Tierney; N Steven; L S Young; A B Rickinson
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

5.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

6.  Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function.

Authors:  S H Ou; L F Garcia-Martínez; E J Paulssen; R B Gaynor
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region.

Authors:  D R Rawlins; G Milman; S D Hayward; G S Hayward
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

8.  Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance.

Authors:  C M Rooney; M Rowe; L E Wallace; A B Rickinson
Journal:  Nature       Date:  1985 Oct 17-23       Impact factor: 49.962

9.  Constitutive binding of EBNA1 protein to the Epstein-Barr virus replication origin, oriP, with distortion of DNA structure during latent infection.

Authors:  D J Hsieh; S M Camiolo; J L Yates
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

10.  Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.

Authors:  E M Deacon; G Pallesen; G Niedobitek; J Crocker; L Brooks; A B Rickinson; L S Young
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  13 in total

1.  The Rous sarcoma virus long terminal repeat promoter is regulated by TFII-I.

Authors:  C M Mobley; L Sealy
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus.

Authors:  D Salamon; M Takacs; D Ujvari; J Uhlig; H Wolf; J Minarovits; H H Niller
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.

Authors:  M G Davenport; J S Pagano
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

4.  Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.

Authors:  Mikio Yoshioka; Michelle M Crum; Jeffery T Sample
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

5.  The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive.

Authors:  Q Tao; K D Robertson; A Manns; A Hildesheim; R F Ambinder
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

6.  Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300.

Authors:  L Burýsek; W S Yeow; B Lubyová; M Kellum; S L Schafer; Y Q Huang; P M Pitha
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

7.  Repression of Epstein-Barr virus EBNA-1 gene transcription by pRb during restricted latency.

Authors:  I K Ruf; J Sample
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

8.  Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.

Authors:  I K Ruf; A Moghaddam; F Wang; J Sample
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  CTCF prevents the epigenetic drift of EBV latency promoter Qp.

Authors:  Italo Tempera; Andreas Wiedmer; Jayaraju Dheekollu; Paul M Lieberman
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

Review 10.  Keeping it quiet: chromatin control of gammaherpesvirus latency.

Authors:  Paul M Lieberman
Journal:  Nat Rev Microbiol       Date:  2013-11-06       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.